DataPeripheral T-cell lymphomas (including cutaneous T-cell lymphoma)

Direct links plus the targets, companies, and technologies of this cancer's products.

• Living with a peripheral T-cell lymphoma, where a trial is more often the right first question: This is orientation from public patient pages, guidelines and the trials themselves, not advice for your case: your own team's instructions and the 24-hour number they gave you come first, and no figure here is a prediction about you. The decision records, the question sets, the first 60 days checklist and the red cards on this page were written from the NHS, Lymphoma Action, Macmillan and Cancer Research UK patient pages, from NICE NG52, NG47, CG151 and NG234, from the NHS Breast Screening Programme protocols and the Green Book, and from the trial reports named beside each figure, all read on 1 October 2026.
• Taxonomy. This page is used as the hub for the mature T-cell and NK-cell lymphomas, which is wider than its name. WHO-HAEM5 reserves "peripheral T-cell lymphoma, not otherwise specified" for a single entity within the family it calls other peripheral T-cell lymphomas, and files the anaplastic large cell lymphomas, the nodal T-follicular helper cell lymphomas, the EBV-positive NK/T-cell lymphomas, the intestinal T-cell lymphomas and the primary cutaneous T-cell lymphomas as separate families. The corpus keeps this page as the entry point because it is where a reader arrives, and the entities now have pages of their own, listed above.

The same record for scripts and assistants; checked 2026-09-08. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.